#6 - Walgreen’s Boots Alliance (NASDAQ:WBA)
In addition to being a free cash flow machine, Walgreen’s (NASDAQ:WBA) does right by its shareholders by paying out a reliable dividend. Not only has the company paid out a dividend every year for 86 years, but it is also a Dividend Aristocrat, having increased its dividend for 43 years running.
However, while Walgreens is an exceptional choice for value investors, the same can’t be said of the stock for growth investors. In the last five years, the stock has underperformed the market and is down over 50% over that period.
But it’s becoming clear to some analysts that the stock is clearly oversold. And Walgreens exists in a sector that tends to hold up well in difficult economic conditions.
In the trailing twelve months ending in May of this year, Pfizer had $4.35 billion in free cash flow. The company’s debt-to-equity ratio is 1.96%. Like Verizon, this is higher than many analysts would like to see. However, it’s well covered by the company’s free cash flow. Walgreen’s also sports an attractive dividend with a yield that is over 5% as of this writing.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
Read More - Current Price
- $8.66
- Consensus Rating
- Reduce
- Ratings Breakdown
- 2 Buy Ratings, 9 Hold Ratings, 4 Sell Ratings.
- Consensus Price Target
- $12.88 (48.8% Upside)
